Sangamo Therapeutics
SGMO
$0.52
Share price
2.12%
Change (1 day)
-68.43%
Change (1 year)
Sangamo Therapeutics (SGMO) - P/B ratio
P/B ratio as of April 2024 : 1.30
According to Sangamo Therapeutics
's latest financial reports the company has a price-to-book ratio of 1.30.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sangamo Therapeutics - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.16 | -33.37% |
| 2022-12-31 | 1.74 | -40.07% |
| 2021-12-31 | 2.91 | -34.41% |
| 2020-12-31 | 4.44 | 97.84% |
| 2019-12-31 | 2.24 | -29.78% |
| 2018-12-31 | 3.19 | -56.7% |
| 2017-12-31 | 7.38 | 366.44% |
| 2016-12-31 | 1.58 | -52.62% |
| 2015-12-31 | 3.34 | -34.34% |
| 2014-12-31 | 5.08 | -28.44% |
| 2013-12-31 | 7.10 | 44.56% |
| 2012-12-31 | 4.91 | 164.22% |
| 2011-12-31 | 1.86 | -65.49% |
| 2010-12-31 | 5.39 | 45.24% |
| 2009-12-31 | 3.71 | 44.14% |
| 2008-12-31 | 2.57 | -64.63% |
| 2007-12-31 | 7.28 | 53.27% |
| 2006-12-31 | 4.75 | 45.76% |
| 2005-12-31 | 3.26 | -30.43% |
| 2004-12-31 | 4.68 | 53.23% |
| 2003-12-31 | 3.06 | 122.63% |
| 2002-12-31 | 1.37 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.24 | 301.88% | 🇺🇸 USA |
 Amgen AMGN | 23.5 | 1,705.45% | 🇺🇸 USA |
 Biogen BIIB | 1.90 | 45.51% | 🇺🇸 USA |
 Dow DOW | 2.10 | 61.22% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.67 | 181.76% | 🇺🇸 USA |
 Merck MRK | 8.54 | 554.88% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -83.7 | -6,519.73% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 3.53 | 170.58% | 🇺🇸 USA |